Arcus Biosciences RCUS Interest and other income, net
Interest and other income, net at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept rcus:InterestAndOtherIncomeExpenseNonoperatingNet.
The official record: Arcus Biosciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arcus Biosciences's interest and other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arcus Biosciences's interest and other income, net?
- Arcus Biosciences (RCUS) reported interest and other income, net of $9M in Q1 2026.
- How has Arcus Biosciences's interest and other income, net changed year-over-year?
- Arcus Biosciences's interest and other income, net decreased by 18.2% year-over-year, from $11M to $9M.
- What is the long-term trend for Arcus Biosciences's interest and other income, net?
- Over 4 years (2021 to 2025), Arcus Biosciences's interest and other income, net has grown at a 153.0% compound annual growth rate (CAGR), from $1M to $41M.
- What does interest and other income, net mean?
- This metric aggregates non-operating financial activities, primarily consisting of interest earned on cash and marketable securities, alongside gains or losses from peripheral activities not related to core biopharmaceutical operations. It provides a view of the company's treasury management performance and the impact of ancillary financial items on the bottom line. By isolating these items from core clinical development costs, stakeholders can better evaluate the company's underlying financial stability and liquidity management.